Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Regenxbio (RGNX.US)$ on 07 Feb will provide an interim clin...

$Regenxbio (RGNX.US)$ on 07 Feb will provide an interim clinical study update of RHX121 for treatment of neuropathic mucopolysaccharaidosis.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
11K Views
Comment
Sign in to post a comment